KAITLYN GOSSARD: Open Payments
NPI 1336821834 · AUGUSTA, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$921 in 50 payments from 19 companies in 2025. Trend: 2023 $0 · 2024 $1,313 · 2025 $921
Food & beverage: $921
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 14 | $238 |
| ABBVIE INC. | 6 | $112 |
| PFIZER INC. | 5 | $88 |
| Exact Sciences Corporation | 4 | $71 |
| AstraZeneca Pharmaceuticals LP | 3 | $54 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $47 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $38 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $34 |
| Amgen Inc. | 2 | $33 |
| Edwards Lifesciences Corporation | 1 | $29 |
Products named: Ozempic, Cologuard Collection Kit, QULIPTA, Wegovy, PREVNAR 20, JARDIANCE, FARXIGA, CAPLYTA.
Industry payments across GA — which companies pay providers there.
